5,6-Diamino-1,3-dimethyl uracil hydrate

CAS : 5440-00-6

Ref. 3D-FD11709

Informations sur le produit

• Nom: 5,6-Diamino-1,3-dimethyl uracil hydrate
• Synonymes: 1,3-Dimethyl-5,6-diaminouracil, 2,4(1H,3H)-Pyrimidinedione, 5,6-diamino-1,3-dimethyl-, 4,5-Diamino-1,3-dimethyl-2,6-dioxotetrahydropyrimidine, 4,5-Diamino-1,3-dimethylpyrimidine-2,6-dione, 4,5-Diamino-1,3-dimethyluracil, 5,6-Diamino-1,3-Dimethyl Uracil, 5,6-Diamino-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione, 5,6-Diamino-1,3-dimethyl-2,4-pyrimidinedione, 5,6-Diamino-1,3-dimethyluracil, 5,6-diamino-1,3-dimethylpyrimidine-2,4(1H,3H)-dione, NSC 15493, Uracil, 5,6-diamino-1,3-dimethyl-

Description

5,6-Diamino-1,3-dimethyl uracil hydrate is a purine derivative that inhibits the growth of cancer cells by blocking the enzyme ribonucleotide reductase. This leads to a decrease in DNA synthesis, protein synthesis, and cell division. The anticancer activity of 5,6-Diamino-1,3-dimethyl uracil hydrate is due to its ability to inhibit the formation of ATP and the GTP cycle. It also has a potent inhibitory effect on the structural analysis of DNA and RNA. 5,6-Diamino-1,3-dimethyl uracil hydrate has been shown to produce apoptotic effects in many types of cancer cells. This drug also has specific agonist properties for G protein coupled receptors that are responsible for activating apoptosis.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 170.17 g/mol
• Formule: C₆H₁₀N₄O₂·xH₂O
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder